BrightInsight announces the appointment of Digital Biotech


SAN JOSE, Calif. And ZURICH, Switzerland, October 19, 2021 (GLOBE NEWSWIRE) – BrightInsight, Inc., a provider of the leading global platform of digital health solutions regulated by biopharma and medical technology, announced today Meinhard F. Schmidt’s membership on the BrightInsight Advisory Board. Mr. Schmidt is the latest health care and tech authority to join this group of 10 advisors working with the BrightInsight leadership team to advance the company’s vision to transform patient outcomes at the global scale through the power of digital technology.

Mr. Schmidt joins the BrightInsight Advisory Council as the company continues its rapid growth trajectory which includes launching digital health solutions in the United States and internationally with leading biopharmaceutical clients including AstraZeneca, CSL Behring, Novo Nordisk and Roche, doubling the staff and tripling its valuation. after a $ 101 million Series C financing round earlier this year led by General Catalyst.

“Meinhard Schmidt has been a friend and informal advisor to BrightInsight, and we are honored to have him officially join our advisory board. His experience in digitizing the biopharmaceutical and medical fields will be invaluable to us as we develop new products and services to meet the growing demand for our regulated digital health platform, ”said Kal Patel, MD, CEO and co- founder. “As we expand our global footprint and product offerings, Meinhard’s experience and network will help accelerate our growth in all areas of the business. “

Mr. Schmidt is an accomplished executive and consultant with over 25 years of global experience in diagnostics, biotechnology, medical technology and digital health, leading transformational change for companies. leading companies as well as start-ups. He has worked in Germany, the Netherlands, the United States, Canada, the United Kingdom, France, Ireland, Sweden, Austria and Switzerland. He currently sits on the boards of several companies, consults with life science organizations to improve innovation, industrialization, commercialization and digitization processes; and advises private equity and venture capital firms to identify investment and acquisition candidates globally. Mr. Schmidt spent ten years at Roche Diagnostics, where he held senior global leadership positions in diabetes care, laboratories and PoC diagnostics. As Executive Vice President of Straumann Institute / Switzerland and CEO of their Digital Dentistry unit, he was responsible for the global digitization of the dental industry.

“I have been impressed with Dr Kal Patel and his team since the inception of BrightInsight. They clearly articulated their vision and then expertly implemented their strategy to enable biopharmaceutical and medical companies to create, scale and maintain regulated digital health products, ”said Meinhard F. Schmidt. “I look forward to working closely with the team to expand BrightInsight’s global leadership position. “

About the BrightInsight Advisory Board
The BrightInsight Advisory Council includes some of the world’s most successful thought leaders in health and technology, including Mark T. Bertolini, Donald Jones, Kothandaraman Sridharan, Jeffrey Leiden, MD, Ph.D., Diana McKenzie, Kim Powell, Brent Saunders, Jagjot (JJ) Singh, Bradley Stock and Hemant Taneja.

About BrightInsight, Inc.

BrightInsight provides the leading global platform for digital health solutions regulated by biopharmacy and medical technologies. When speed matters, we help companies accelerate time-to-market for regulated digital health offerings across all therapeutic areas, including applications, algorithms, medical devices, connected handsets, diagnostics and software. as a medical device (SaMD). BrightInsight replaces the need for lengthy and complex “from scratch” implementations by offering configurable software modules and a proven platform built under a quality management system to support global security, privacy and security requirements. regulatory. When building digital health products on the BrightInsight platform, compliance is sustainable as the intended use changes geographically.

For more information visit BrightInsight website, Blog, Twitter, and LinkedIn pages.

BrightInsight and the BrightInsight logo are trademarks of BrightInsight, Inc. Other company and product names are provided for identification purposes only and may be trademarks of their respective owners.

Media & Press
Jamie burgess
Senior Vice President, Marketing, BrightInsight
[email protected]

Helene shik
Shik Communications
[email protected]

A photo accompanying this announcement is available at


Comments are closed.